﻿<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="https://cdn.mysitemapgenerator.com/api/feedpreview_s.2e27a11a396f162a7ea061bf1846c282.xsl"?>
		<!--	created with www.mysitemapgenerator.com	-->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>www.who.int</title>
		<link><![CDATA[https://www.who.int/]]></link>
		<description>News from the World Health Organization</description>
		<language>en</language>
		<pubDate>Wed, 15 Jul 2026 13:06:38 +0000</pubDate>
		<generator>MySitemapGenerator (www.mysitemapgenerator.com)</generator>

		<item>
			<guid isPermaLink="false">2206488540</guid>
			<title>Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women</title>
			<link>https://www.who.int/publications/i/item/9789240124110</link>
			<dc:creator>HIV, TB, Hepatitis and STIs (HTH)</dc:creator>
			<description>This guideline provides evidence-informed recommendations on the use of doxycycline post-exposure prophylaxis (PEP) for the prevention of bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women, populations disproportionately affected by STIs.</description>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0200</pubDate>
			<enclosure url="https://iris.who.int/server/api/core/bitstreams/7493357f-da0e-402d-b406-9a0d939a6486/content" />
		</item>
		<item>
			<guid isPermaLink="false">1397576021</guid>
			<title>WHO target product profile for Bundibugyo virus disease vaccines, 14 July 2026</title>
			<link>https://www.who.int/publications/i/item/B09835</link>
			<dc:creator>R&amp;D Blueprint (RDB)</dc:creator>
			<description>The publication outlines the intended public health use of Bundibugyo virus vaccines in outbreak response and preparedness, including their role in protecting at-risk populations and contributing to outbreak control. It describes the desired vaccine attributes across key domains, including indications, target populations, efficacy, safety, dosing regimen, route of administration, storage and stability, manufacturing considerations, and programmatic suitability for deployment in resource-constrained settings. The document also explains how the TPP is intended to support the World Health Organization policy recommendations, Emergency Use Listing, prequalification, and regulatory decision-making, while recognizing that overall benefit-risk considerations may outweigh individual product characteristics. Intended for vaccine developers, manufacturers, researchers, regulators, funding agencies and public health partners, this TPP provides a common framework to accelerate the development, evaluation and availability of safe, effective and accessible vaccines for the prevention and control of Bundibugyo virus disease.</description>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0200</pubDate>
			<enclosure url="https://iris.who.int/server/api/core/bitstreams/854a9591-f3a0-409d-a6d3-c4cca952c27f/content" />
		</item>
		<item>
			<guid isPermaLink="false">1033154846</guid>
			<title>The Diagnostic testing for Ebola disease and Marburg virus disease: interim guidance, 9 July 2026</title>
			<link>https://www.who.int/publications/i/item/B09834</link>
			<dc:creator>Epidemic and Pandemic Management (EPM)</dc:creator>
			<description>This document constitutes an update to the Diagnostic testing for Ebola and Marburg virus diseases: interim guidance, 20 December 2024. It provides interim guidance to laboratory personnel, clinicians, health workers, public health officials, outbreak response teams, and other stakeholders involved in the diagnosis and care of patients with suspected or confirmed EBOD or MVD, from specimen collection through to diagnostic analysis and reporting.</description>
			<pubDate>Mon, 13 Jul 2026 00:00:00 +0200</pubDate>
			<enclosure url="https://iris.who.int/server/api/core/bitstreams/2acf5e6f-35d4-4a47-956e-f5b368d65962/content" />
		</item>
		<item>
			<guid isPermaLink="false">3873302692</guid>
			<title>Disarmament, demobilization and reintegration and mental health and psychosocial support: operational guidance</title>
			<link>https://www.who.int/publications/i/item/9789240121706</link>
			<dc:creator>Noncommunicable Diseases and Mental Health (NMH)</dc:creator>
			<description>This operational guidance addresses the integration of mental health and psychosocial support (MHPSS) into disarmament, demobilization and reintegration (DDR) processes in conflict and post-conflict settings. It highlights how prolonged exposure to armed conflict, community stigma, family separation, loss of livelihoods and other adversities can affect the mental health and psychosocial well-being of people formerly recruited or associated with armed forces and armed groups, including children, women and their families</description>
			<pubDate>Fri, 10 Jul 2026 00:00:00 +0200</pubDate>
			<enclosure url="https://iris.who.int/server/api/core/bitstreams/1da8844c-588d-4d73-ba93-f5ecd63149f7/content" />
		</item>
	</channel>
</rss>